Business · 14/05/2020Updated: 10/17/2026 · 1 min read
Janssen Pharmaceuticals, Inc., et al.; Withdrawal of Approval of 16 New Drug Applications
Summary
The Food and Drug Administration (FDA) is withdrawing approval of 16 new drug applications from multiple applicants, including Janssen Pharmaceuticals, Inc., after the applicants notified the agency that the drug products are no longer on the market.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →